The Jarvi laboratory currently has two main areas of investigation: avian pathogens and rat lungworm disease.
Susan Jarvi is a professor of pharmaceutical sciences and director of the pre-pharmacy program at the Daniel K. Inouye College of Pharmacy, University of Hawai‘i at Hilo. She researches host-parasite and parasite-parasite interactions and influences on transmission and virulence of infectious disease.
Jarvi is studying tolerance to infectious disease as evidenced through a recent population explosion of a low elevation native Hawaiian bird population despite high prevalence of Plasmodium infection. Her goal is to characterize and begin to define potentially novel mechanisms involved in tolerance to malaria in this relatively simple, geographically-isolated, natural disease system.
Jarvi’s lab, located at the Daniel K. Inouye College of Pharmacy at UH Hilo, currently has two main areas of investigation: avian pathogens and rat lungworm disease. The research team also is interested in continued development of molecular-based methods for the detection and evaluation of pathogen diversity, and development and implementation of vaccines.
A main focus of the Jarvi lab is host-parasite and parasite-parasite interactions involving the genetic analysis of avian pathogens (Plasmodium relictum and Avipoxvirus) and avian hosts toward a better understanding of the evolution of disease susceptibility. While most species of Hawaiian honeycreeper are highly susceptible to avian malaria, populations of the Hawai‘i ‘amakihi (Hemignathus virens) are thriving at low elevations on Hawai‘i Island despite high infection rates of Plasmodium relictum.
Toward determining the genes involved in survival, Jarvi and her research team are evaluating major histocompatibility complex (MHC) genes in ‘amakihi by traditional cloning and sequencing as well as by 454 Roche platform next-generation sequencing. They also have conducted amplified fragment length polymorphism (AFLP) studies to look for candidate genes involved in survival.
“Many years ago, we demonstrated that variation exists among avian malaria parasites in Hawai‘i,” she explains. Since then, the State of Hawai‘i requires that any birds being moved between islands be tested for malaria, and positive birds not be moved.”
Jarvi’s and her team are the leaders in molecular diagnostics for both malaria and poxvirus in Hawai‘i. Recently, the population of nene geese near the Kaua‘i airport was determined to be too large and causing interference with air travel.
“We have been testing samples for the state to determine infection status for potential translocation of nene,” she explains. “We are concurrently completing a comprehensive statewide survey of malaria diversity by 454 Roche platform sequencing. We have shown that at least two variants of avipoxvirus exist in Hawai‘i and that one is more virulent than the other. We are in the process of sequencing these variants to determine the genes involved in virulence.”
In the host-parasite studies of susceptibility of ‘amakihi to avian malaria, MHC analysis revealed a significant association between survivorship and the presence of one or more MHC alleles. This is the first documentation of an MHC association with survival to malaria in Hawaiian honeycreepers. The research team also conducted AFLP studies to look for candidate genes involved in survival. Sequence information was obtained from a total of 139 clones of AFLP bands. They identified five genes that are candidate genetic markers for survival.
Currently Jarvi and the research team are finishing a statewide survey of diversity of avian malaria in Hawai‘i and analyzing data from host genetic studies. They hope to be able to provide needed data to apply towards conservation efforts.
“The totality of this research is inherently conservation work and has the potential to help save native Hawai‘i honeycreepers,” Jarvi says.
Rat lungworm disease
A second research focus of Jarvi’s lab is rat lungworm disease (RLWD) caused by the parasite Angistrongylus cantonensis.
“Hawai‘i, specifically the Puna district on the Island of Hawai‘i, is the epicenter for RLWD in the U.S.,” says Jarvi.
Jarvi and team have completed two trials in local rats with USDA Animal and Plant Health Inspection Service (APHIS). One was to see if detection of parasite DNA was possible in rat blood in hopes of developing an early diagnostic test for humans. The other was to determine the efficacy of a vaccine against RLW in local rats (they concluded that a vaccine developed in Spain was not effective in stopping the development of RLW in rats under the conditions of the trial).
They also are evaluating the possibility of RLW larvae transmission in catchment water. They were surprised to discover RLW larvae can live a long time in rainwater. (Another surprising find is that rats can harbor dozens of adult worms in their hearts and lungs, which had to pass through their brains, with no apparent ill effect.)
The research approaches include developing a qPCR test to estimate the parasite load in intermediate hosts (slugs and snails). This allows researchers to evaluate the level of infection looking for transmission “hotspots.”
- See paper on research, “Quantitative PCR estimates Angiostrongylus cantonensis (rat lungworm) infection levels in semi-slugs (Parmarion martensi).”
“We have evaluated how well some solutions are at killing RLW larvae,” Jarvi says of the research activity. “We have determined that RLW larvae can live up to 20 days in rainwater, thus could likely live that long in catchment tanks. We determined that RLW DNA can be detected in the blood of infected rats at some time periods throughout infection. We are working on getting antibody-based diagnostic test running on-island.”
- See also the informational page on Jarvi’s website, “Rat Lungworm Overview”.
For two years, Jarvi and other researchers in the state have made considerable progress towards reducing RLWD through educational and research approaches. They have provided public forums, talks, handouts, brochures and are in the process of integrating RLWD education into the Hawai‘i DOE curriculum. They produced and piloted an activity book, The Mystery of Rat Lungworm Disease, in four East Hawai‘i schools for second graders.
“This was very well-received, and we are in the process of distribution across the islands and state,” she says. The researchers also are developing a “junior investigator scientific journal” that will encompass many STEM disciplines while learning about RLWD for tenth grade students.
Currently Jarvi and the RLWD research team are working with catchment tanks to test filtration and UV systems to see if RLW larvae can make it through. They also are gearing up to conduct a pilot study to test 500 volunteers for the presence of RLW antibodies to better understand the prevalence. They are working with Puna Medical Center and Clinical Lab for blood collection. Meanwhile, they continue to educate the community about RLWD and how to best prevent it.
“Our RLWD educational and research efforts will help save lives,” says Jarvi. “RLWD is a very preventable disease, if you know about it. Education is key, and we are providing activity books to keiki (children) who can then go home and educate their ‘ohana (family).”
Future goals of the RLWD project are to continue to educate the public toward minimizing infection, to develop reliable diagnostics for health providers, and develop management plans that would reduce slug, snail, and rat population numbers.
Jarvi received her master of science in veterinary and animal sciences (avian genetics) from the University of Massachusetts at Amherst, and her doctor of philosophy in biology (immunogenetics) from Northern Illinois University at DeKalb.